Q32 Bio (QTTB) Other Accumulated Expenses (2017 - 2023)

Q32 Bio's Other Accumulated Expenses history runs 7 years deep, the most recent figure standing at $325000.0 for Q4 2023.

• On a quarterly basis, Other Accumulated Expenses fell 96.56% year-over-year to $325000.0 in Q4 2023; TTM through Dec 2023 was $325000.0, a 96.56% decrease from a year earlier, with the FY2023 full-year figure at $325000.0, down 96.56% from the prior year.
• Other Accumulated Expenses climbed to $325000.0 in Q4 2023 per QTTB's latest filing, from $205000.0 in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $12.6 million in Q2 2023 and bottomed at $37000.0 in Q4 2021.
• The 5-year median for Other Accumulated Expenses is $919500.0 (2019), against an average of $2.9 million.
• Across the five-year window, Other Accumulated Expenses surged 25432.43% in 2022 and plunged 98.1% in 2023, its largest moves.
• Year by year, Other Accumulated Expenses stood at $2.3 million in 2019, then slumped by 90.97% to $204000.0 in 2020, then tumbled by 81.86% to $37000.0 in 2021, then jumped by 25432.43% to $9.4 million in 2022, then sank by 96.56% to $325000.0 in 2023.
• Per Business Quant, the three latest QTTB Other Accumulated Expenses figures stand at $325000.0 (Q4 2023), $205000.0 (Q3 2023), and $12.6 million (Q2 2023).